ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer

Takahiro Sato(Kanazawa University), Koji Kono(Fukushima Medical University)
Gastric Cancer
February 22, 2023
Cited by 9


Related Papers